Decreased Empathy and Emotion Recognition in Patients With Neurodegenerative Disease

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

75 participants

Study Classification

INTERVENTIONAL

Study Start Date

2019-07-22

Study Completion Date

2022-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study evaluates an educational brochure tailored to caregivers of people with Alzheimer's disease, Parkinson's disease dementia, Lewy body disease, frontotemporal dementia, and vascular disease dementia. The goal of the brochure is educating caregivers about the decreased ability to detect emotion and decreased empathy that can be seen in dementia, increasing caregiver competence in providing care, and teaching caregivers ways to manage over time that lessens burden and improves quality of life.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Social Cognition and Personality Changes in Alzheimer's & Parkinson's Disease & Frontotemporal Lobar Degeneration

NCT02964611

Alzheimer's Disease Parkinson's Disease Frontotemporal Lobar Degeneration

COMPLETED

Supporting Caregivers of Persons With Dementia: A Pilot Study

NCT00908492

Alzheimer Disease Dementia

COMPLETED PHASE2/PHASE3

Effect of Cognitive Empathy Training on Dementia Caregivers

NCT06650527

Caregivers of People Living With Dementia Dementia

RECRUITING NA

A Mobile Application for Training of Family Caregivers Caring for Someone With Dementia

NCT04139707

Dementia

UNKNOWN NA

Sensory Support Care for Elderly Patients Suffering From Alzheimer'S-type Neurodegenerative Disease

NCT01819714

Alzheimer Disease

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The 1.5-hour initial visit will involve the caregiver completing questionnaires, structured interviews, and a computer task, and the person with dementia completing a computer task. A 20-30 minute follow-up phone call with the caregiver one month after the initial visit will involve completing questionnaires.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Neuro-Degenerative Disease Dementia Caregiver Burnout Alzheimer Disease Frontotemporal Lobar Degeneration Parkinson Disease Vascular Dementia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Every caregiver and patient dyad will complete the study tasks. The caregiver will receive a 1 month follow up call.

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Interventional Arm

The Interventional Arm will receive the educational brochure and complete the study tasks and questionnaires.

Group Type EXPERIMENTAL

Educational Brochure

Intervention Type BEHAVIORAL

Educational brochure on decreased empathy and emotion recognition in patients with neurodegenerative disease

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Educational Brochure

Educational brochure on decreased empathy and emotion recognition in patients with neurodegenerative disease

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* All caregivers who visit the UHN Memory Clinic with a patient with a neurodegenerative disease will be asked to participate.
* The patient must be aged 50 to 95 (inclusive) and speak English
* The caregiver must be aged 30 to 95 (inclusive) and speak English.
* The patients must have a diagnosis of one of the following conditions: Alzheimer's Disease, Parkinson's Disease/Dementia with Lewy Body, Frontotemporal Lobar Degeneration-syndromes or Vascular Dementia.
* The patient must have a Montreal Cognitive Assessment (MOCA) score of 10-25

Exclusion Criteria

* Not English speaking.
* Patients who do not have a caregiver that would be able to participate in the study.
* Caregivers who do not have a patient being followed at the UHN Memory Clinic

Minimum Eligible Age

30 Years

Maximum Eligible Age

95 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No